These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15691636)

  • 21. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE
    J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY; Ren GS; Arnould N; Brettes JP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative surgery for infiltrating lobular breast carcinoma.
    Salvadori B; Biganzoli E; Veronesi P; Saccozzi R; Rilke F
    Br J Surg; 1997 Jan; 84(1):106-9. PubMed ID: 9043471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Goldstein NS; Kestin LL; Vicini FA
    Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
    Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
    Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].
    Zinzindohoué C; Bobin JY
    Bull Cancer; 1998 Sep; 85(9):763-72. PubMed ID: 9817060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
    Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiotherapy of in situ carcinoma of the breast. EORTC Breast Group].
    Julien JP
    Praxis (Bern 1994); 1998 Apr; 87(15):520-3. PubMed ID: 9608248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
    Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bilateral breast carcinoma. 12 years' experience].
    Maculotti L; Gandini F; Pradella P
    Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of in situ cancer.
    Recht A; Connolly JL; Schnitt SJ; Harris JR
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lobular neoplasia on core needle biopsy does not require excision.
    Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
    Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up.
    Vujovic O; Cherian A; Yu E; Dar AR; Stitt L; Perera F
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):687-90. PubMed ID: 16949764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy.
    Moran M; Haffty BG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):353-8. PubMed ID: 9457821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of carcinoma in situ of the breast].
    Raudrant D; Golfier F; Unger P
    Rev Fr Gynecol Obstet; 1990 Feb; 85(2):91-6. PubMed ID: 2157271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoma in situ of the breast: which treatment?].
    Antonello M; Polico R; Busetto M; Schiavon S; Pizzi G
    Radiol Med; 1994 Nov; 88(5):661-4. PubMed ID: 7824785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.